DDS Clostridium Botulinum

First Page		Document Content
Date: 2014-03-05 12:02:53 Neurotoxins Neurological disorders Clostridiaceae Gram-positive bacteria Botulinum toxin Plastic surgery Clostridium Spasmodic torticollis Dystonia Biology Microbiology Medicine		DDS Clostridium Botulinum Add to Reading List Source URL: www.health.gov.bc.ca Download Document from Source Website File Size: 403,08 KB Share Document on Facebook

	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use DYSPORT® safely and effectively. See full prescribing information for DYSPORT®. DocID: 1oBwA - View Document
	BLA STNFDA APPROVED LABELING TEXT HIGHLIGHTS OF PRESCRIBING INFORMTION These highlights do not include all the information needed to use . Blepharospasm: 1.25 Units-2.5 Units into each of 3 sites per affec DocID: 1nR51 - View Document
	ATTACHMENT # 2 to the UNOPPOSED MOTION OF THE NATIONAL SPASMODIC TORTICOLLIS ASSOCIATION, THE NATIONAL SPASMODIC DYSPHONIA ASSOCIATION, ALLIED EDUCATIONAL FOUNDATION, AND WASHINGTON LEGAL FOUNDATION FOR LEAVE TO FILE AS DocID: 1l2Ba - View Document
	Clostridium botulinum neurotoxin type A (Xeomin) for sialorrhoea associated with adult Parkinson’s disease and paediatric cerebral palsy DocID: 1fM0Q - View Document
	PRESS RELEASE MERZ NEUROSCIENCES TO PRESENT KEY CLINICAL DATA AT THE ANNUAL MEETING OF THE AMERICAN ACADEMY OF NEUROLOGY (AAN) DocID: 1a1Yq - View Document